During the past decade, Greenville Hospital System University Medical Center (ITOR) conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 8 clinical trials were completed, i.e. on average, 72.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 8 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Greenville Hospital System University Medical Center (ITOR)" #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 4 trials, followed by "Sumitomo Pharma Oncology, Inc." with 3 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "OncoMed Pharmaceuticals, Inc." with 2 trials sponsored and "ADC Therapeutics S.A." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Greenville Hospital System University Medical Center (ITOR)" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Greenville Hospital System University Medical Center (ITOR)" are "Colorectal Cancer" (2 trials), "Metastatic Pancreatic Cancer" (2 trials), "Non-small Cell Lung Cancer" (2 trials), "Pancreatic Cancer" (2 trials) and "Solid Tumors" (2 trials). Many other conditions were trialed in "Greenville Hospital System University Medical Center (ITOR)" in a lesser frequency.

Most popular intervention types in "Greenville Hospital System University Medical Center (ITOR)" are "Drug" (21 trials), "Other" (2 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (3 trials), "Avelumab" (2 trials), "BBI608" (2 trials), "Carboplatin" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Greenville Hospital System University Medical Center (ITOR)" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Greenville Hospital System University Medical Center (ITOR)". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Greenville Hospital System University Medical Center (ITOR), undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Greenville Hospital System University Medical Center (ITOR), 20 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".